The University of Southampton
University of Southampton Institutional Repository

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.

The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.
The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial.
BackgroundFor adults surviving stroke due to spontaneous (non-traumatic) intracerebral haemorrhage (ICH) who had taken an antithrombotic (i.e. anticoagulant or antiplatelet) drug for the prevention of vaso-occlusive disease before the ICH, it is unclear whether starting antiplatelet drugs results in an increase in the risk of recurrent ICH or a beneficial net reduction of all serious vascular events compared to avoiding antiplatelet drugs.Methods/designThe REstart or STop Antithrombotics Randomised Trial (RESTART) is an investigator-led, randomised, open, assessor-blind, parallel-group, randomised trial comparing starting versus avoiding antiplatelet drugs for adults surviving antithrombotic-associated ICH at 122 hospital sites in the United Kingdom. RESTART uses a central, web-based randomisation system using a minimisation algorithm, with 1:1 treatment allocation to which central research staff are masked. Central follow-up includes annual postal or telephone questionnaires to participants and their general (family) practitioners, with local provision of information about adverse events and outcome events. The primary outcome is recurrent symptomatic ICH. The secondary outcomes are: symptomatic haemorrhagic events; symptomatic vaso-occlusive events; symptomatic stroke of uncertain type; other fatal events; modified Rankin Scale score; adherence to antiplatelet drug(s). The magnetic resonance imaging (MRI) sub-study involves the conduct of brain MRI according to a standardised imaging protocol before randomisation to investigate heterogeneity of treatment effect according to the presence of brain microbleeds. Recruitment began on 22 May 2013. The target sample size is at least 720 participants in the main trial (at least 550 in the MRI sub-study).DiscussionFinal results of RESTART will be analysed and disseminated in 2019.Trial registrationISRCTN71907627 ( www.isrctn.com/ISRCTN71907627 ). Prospectively registered on 25 April 2013.
1745-6215
Al-Shahi, Salman R
04a9ae6b-1d96-4c4e-a9b7-b996a756641e
Innes, K
4423c9f2-75f4-4265-b550-aaec6f490c26
Drever, J
67cfa56d-b95e-4fe2-9352-e3c9febc81c1
Dinsmore, L
b1774b81-128d-49a3-9e8c-e1e6004a7050
Williams, C
2f3c5203-6fbe-432d-a2ad-f039983069e4
Sprigg, N
e3b7cfda-3b49-4c8f-b5cb-b13a77debaf9
Al-Shahi, Salman R
04a9ae6b-1d96-4c4e-a9b7-b996a756641e
Innes, K
4423c9f2-75f4-4265-b550-aaec6f490c26
Drever, J
67cfa56d-b95e-4fe2-9352-e3c9febc81c1
Dinsmore, L
b1774b81-128d-49a3-9e8c-e1e6004a7050
Williams, C
2f3c5203-6fbe-432d-a2ad-f039983069e4
Sprigg, N
e3b7cfda-3b49-4c8f-b5cb-b13a77debaf9

Al-Shahi, Salman R, Innes, K, Drever, J, Dinsmore, L, Williams, C and Sprigg, N (2018) The REstart or STop Antithrombotics Randomised Trial (RESTART) after stroke due to intracerebral haemorrhage: study protocol for a randomised controlled trial. Trials, 19 (162). (doi:10.1186/s13063-018-2542-6).

Record type: Article

Abstract

BackgroundFor adults surviving stroke due to spontaneous (non-traumatic) intracerebral haemorrhage (ICH) who had taken an antithrombotic (i.e. anticoagulant or antiplatelet) drug for the prevention of vaso-occlusive disease before the ICH, it is unclear whether starting antiplatelet drugs results in an increase in the risk of recurrent ICH or a beneficial net reduction of all serious vascular events compared to avoiding antiplatelet drugs.Methods/designThe REstart or STop Antithrombotics Randomised Trial (RESTART) is an investigator-led, randomised, open, assessor-blind, parallel-group, randomised trial comparing starting versus avoiding antiplatelet drugs for adults surviving antithrombotic-associated ICH at 122 hospital sites in the United Kingdom. RESTART uses a central, web-based randomisation system using a minimisation algorithm, with 1:1 treatment allocation to which central research staff are masked. Central follow-up includes annual postal or telephone questionnaires to participants and their general (family) practitioners, with local provision of information about adverse events and outcome events. The primary outcome is recurrent symptomatic ICH. The secondary outcomes are: symptomatic haemorrhagic events; symptomatic vaso-occlusive events; symptomatic stroke of uncertain type; other fatal events; modified Rankin Scale score; adherence to antiplatelet drug(s). The magnetic resonance imaging (MRI) sub-study involves the conduct of brain MRI according to a standardised imaging protocol before randomisation to investigate heterogeneity of treatment effect according to the presence of brain microbleeds. Recruitment began on 22 May 2013. The target sample size is at least 720 participants in the main trial (at least 550 in the MRI sub-study).DiscussionFinal results of RESTART will be analysed and disseminated in 2019.Trial registrationISRCTN71907627 ( www.isrctn.com/ISRCTN71907627 ). Prospectively registered on 25 April 2013.

Text
s13063-018-2542-6 - Version of Record
Available under License Creative Commons Attribution.
Download (963kB)

More information

Accepted/In Press date: 12 February 2018
Published date: 5 March 2018

Identifiers

Local EPrints ID: 506034
URI: http://eprints.soton.ac.uk/id/eprint/506034
ISSN: 1745-6215
PURE UUID: 53ff5acb-3c46-48da-a1ac-524c15cf8f30

Catalogue record

Date deposited: 28 Oct 2025 17:32
Last modified: 28 Oct 2025 17:41

Export record

Altmetrics

Contributors

Author: Salman R Al-Shahi
Author: K Innes
Author: J Drever
Author: L Dinsmore
Author: C Williams
Author: N Sprigg

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×